Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis
Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idio...
28 Syys 20259min
Joan Soriano on Global Epidemiology of Respiratory Disease
Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challe...
17 Heinä 202510min
Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
This episode is in Italian. For the English version, please see the main feed. Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare...
16 Heinä 202514min
Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat T...
16 Heinä 202518min
Laura Garriga-Grimau on bronchiectasis in children and young people
Deputy editor Ari Colosio speaks with Dr. Laura Garriga-Grimau of the Val d’Hebron Hospital, Autonomous University of Barcelona. Dr. Garriga-Grimau discusses the first multi-country cohort study to de...
2 Heinä 202512min
Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS
Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenoty...
4 Kesä 202511min
Hjalmar Bouma on sepsis in patients who are immunocompromised
Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challen...
20 Touko 202513min
Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019
Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the U...
7 Huhti 202511min
